13 Nov Redx Anti-infectives
Redx Anti-Infectives Ltd is a wholly-owned subsidiary of Redx Pharma, a UK-based company discovering and developing new therapeutics for the global pharmaceutical market.
Redx has successfully applied its proprietary Redox Switch™ approach in the area of infectious disease generating a pipeline of novel antibacterial and antiviral drugs.
The recent calls from the World Health Organisation and the UK’s Chief Medical Officer for greater efforts to be invested in the discovery of new antibiotics have highlighted the chronic lack of new therapies in this area. Redx Anti-Infectives, in collaboration with its partners, is playing its part in tackling this issue with a key focus on developing drugs to combat antibiotic resistance.